Zhuang, J., Zhang, S., Zhang, X., Qiu, X., Zheng, X., Gao, J., Guo, H. (2025). A prospective phase II study to evaluate olaparib plus abiraterone and prednisone combination therapy in metastatic hormone sensitive prostate cancer patients with HRR gene mutation: Updated analysis of PROact.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2025.43.5_suppl.tps292